Clicky

Luye Pharma Group Ltd(2186)

Description: Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.


Keywords: Medicine Cancer Pharmaceutical Products Diabetes Surgery Solid Tumors Radiation Breast Cancer Alzheimer's Disease Non Small Cell Lung Cancer Ovarian Cancer Osteoporosis Osteoarthritis Schizophrenia Chronic Pain Opioids Pharmacokinetics Diarrhea Liver Cancer Radiotherapy Biopharmaceutical Products Phenols Treatment Of Alzheimer's Disease Pharmaceutical Drugs Transdermal Patch Buprenorphine Contraception Fentanyl Malignant Tumors Adjuvant Therapy Pains Seroquel Xr Respiratory Infections Dermal Patch Medical Signs Treatment Of Diarrhea Treatment Of Various Types Of Cancers Pioglitazone Hydrochloride

Home Page: www.luye.cn

No. 15 Chuang Ye Road
Yantai, 264003
China
Phone:


Officers

Name Title
Mr. Dian Bo Liu Co-Founder, Exec. Chairman, CEO and Head of Corp. Directions & Strategies
Mr. Rong Bing Yang Co-Founder & Vice Exec. Chairman
Mr. Hui Xian Yuan Co-Founder & Exec. Director
Ms. Yuan Yuan Zhu Exec. Director
Mr. Yuan Chong Liu Chief Financial Officer
Ms. Yun Li Xue Sr. VP & GM of Shandong Luye
Dr. You Xin Li Head of R&D and Sr. VP
Ms. Mei Yi Lee ACIS, ACS, FCIS, FCS Company Sec.
Mr. Zhi Cheng Fan Chief Engineer of Shandong Luye Pharmaceutical Co Ltd
Li Ping Loh Assistant Company Sec.

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 20.6186
Trailing PE: 11.3225
Price-to-Book MRQ: 1.2436
Price-to-Sales TTM: 2.4503
IPO Date: 2004-05-05
Fiscal Year End: December
Full Time Employees: 4800
Back to stocks